Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Increased Risk for Development of Breast Cancer
Interventions: DRUG: bazedoxifene plus conjugated estrogens
Sponsor: Carol Fabian, MD